HBV-specific T cells as a Biomarker for Discontinuation of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B

類似資料

• Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
  著者:: Kim, Soon Sun, 等
  出版事項: (2011)
• Hepatitis B virus–specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation
  著者:: Rivino, Laura, 等
  出版事項: (2018)
• Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis B
  著者:: Papatheodoridi, Margarita, 等
  出版事項: (2020)
• Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
  著者:: Jung, Sang Kyung, 等
  出版事項: (2015)
• Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients
  著者:: Young Jip Kim, 等
  出版事項: (2013-09-01)